Investing.com - Financial Markets Worldwide
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

DuPont (DD) To Upgrade Probiotics Facility In Wisconsin

ByZacks Investment Research
Published 08/23/2017, 10:03 PM
Updated 07/09/2023, 06:31 AM
US500
-
DOW
-
DD
-
BASFY
-
CC
-
DuPont’s (NYSE:DD) Nutrition & Health segment has announced that it will expand its probiotics pilot facility in Madison, WI. The $10 million investment will further reinforce DuPont’s position as a leading player in the probiotics industry. Further, this will expedite the development of new products and significantly hasten the delivery of pilot materials for clinical trials and customer evaluations.
The Madison probiotics pilot area provides increased capacity and speed for new product development. This in turn helps to improve the overall scale up capability and provides a seamless transition to commercial scale production. Construction of this area has been completed in phases over the last six months.
The new facility features state-of-the-art equipment, data collection, laboratories, instrumentation and specialized work space for probiotic development and scale up. The upgrades have already increased the bandwidth to run more development projects while improving scale up efficiency and time to market.
DuPont has outperformed the industry over the last three months. The company’s shares have moved up 6.9% over this period, compared with the industry’s gain of around 4.7% over the same period.
DuPont kept its positive earnings surprise streak alive with a solid beat in second-quarter 2017. The company recorded adjusted earnings of $1.38 per share in the reported quarter, up 11% from $1.24 per share a year ago. Results topped the Zacks Consensus Estimate of $1.29. DuPont logged net sales of $7,424 million, up roughly 5% year over year on higher volumes. The figure surpassed the Zacks Consensus Estimate of $$7,260 million.
DuPont is well positioned to gain from its cost-cutting and productivity improvement measures and product launches. The company has numerous new products in its pipeline that are expected to create value for customers.
Moreover, the planned mega-merger with Dow Chemical (NYSE:DOW) is expected to deliver cost synergies of around $3 billion and growth synergies of roughly $1 billion. The companies expect the closing of the merger to take place on Aug 31.
E.I. du Pont de Nemours and Company Price and Consensus

E.I. du Pont de Nemours and Company Price and Consensus | E.I. du Pont de Nemours and Company Quote

Zacks Rank & Stocks to Consider

DuPont currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the chemical space are BASF SE (OTC:BASFY) and The Chemours Company (NYSE:CC) . Both the stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

BASF has an expected long-term earnings growth of 8.6%.

Chemours has an expected long-term earnings growth of 15.5%.

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>



E.I. du Pont de Nemours and Company (DD): Free Stock Analysis Report

Dow Chemical Company (The) (DOW): Free Stock Analysis Report

BASF SE (BASFY): Free Stock Analysis Report

Chemours Company (The) (CC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.